UK markets closed

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.1372+0.0058 (+4.42%)
As of 01:11PM EDT. Market open.
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
3,130
5,362
7,504
11,952
-
Total cash
3,130
5,362
7,504
11,952
-
Net receivables
759
1,973
1,668
1,106
-
Inventory
2,877
3,437
3,220
608
-
Other current assets
81
159
129
102
-
Total current assets
7,154
11,332
13,170
14,242
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,056
2,572
1,245
1,122
-
Accumulated depreciation
-673
-622
-641
-602
-
Net property, plant and equipment
1,383
1,950
604
520
-
Goodwill
0
348
4,528
0
-
Intangible assets
-
2,280
5,200
-
-
Other long-term assets
497
489
476
476
-
Total non-current assets
1,880
5,067
10,808
996
-
Total assets
9,034
16,399
23,978
15,238
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
1,137
-
105
-
2,611
Accounts payable
1,130
1,080
1,045
302
-
Accrued liabilities
570
917
803
1,385
-
Deferred revenues
946
1,807
1,289
730
-
Other current liabilities
-
-
-
-
37
Total current liabilities
4,278
4,257
3,442
2,833
-
Non-current liabilities
Other long-term liabilities
334
-
561
-
4,055
Total non-current liabilities
1,442
1,588
10,365
87
-
Total liabilities
5,720
5,845
13,807
2,920
-
Stockholders' equity
Common stock
2,062
2,993
1,158
418
-
Retained earnings
-174,849
-158,152
-141,887
-136,063
-
Total stockholders' equity
3,314
10,554
10,171
12,318
-
Total liabilities and stockholders' equity
9,034
16,399
23,978
15,238
-